RICINUS COMMUNIS (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)


Welcome to the PulseAid listing for the RICINUS COMMUNIS drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
NON-PROPRIETARY NAME: RICINUS COMMUNIS
SUBSTANCE NAME: RICINUS COMMUNIS SEED
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-12-27
END MARKETING DATE: 0000-00-00


RICINUS COMMUNIS HUMAN OTC DRUG Details:

Item DescriptionRICINUS COMMUNIS from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
LABELER NAME: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 1([hp_X]/1)
START MARKETING DATE: 2015-12-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15631-0670_c74d1499-d5e1-44b0-b868-5f78ee78ce8d
PRODUCT NDC: 15631-0670
APPLICATION NUMBER:

Other RICINUS COMMUNIS SEED Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Rxhomeo Private Limited d.b.a. Rxhomeo, IncRICINUS COMMUNIS
Washington Homeopathic ProductsRicinus communis